Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin plus oral vinorelbine plus cisplatin vs oral vinorelbine plus cisplatin in stage IIIB/IV NSCLC
2007-001262-32Phase 2Completed
- Sponsor
- GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitroglycerin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH. Primary endpoint: Overall response rate. Started Apr 2007; status: completed.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-001262-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001262-32.